- Home
- AMBA vs RLAY Comparison
AMBA vs RLAY Comparison
Compare AMBA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMBA | RLAY |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.8B |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AMBA | RLAY |
|---|---|---|
| Price | $67.00 | $18.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $89.36 | $27.58 |
| AVG Volume (30 Days) | 1.2M | ★ 2.4M |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.32 | 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $295,402,000.00 | $15,355,000.00 |
| Revenue This Year | $12.88 | N/A |
| Revenue Next Year | $13.35 | $60.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $48.30 | $5.95 |
| 52 Week High | $96.69 | $21.27 |
Technical Indicators
Market Signals| Indicator | AMBA | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 49.28 |
| Support Level | $59.89 | $16.68 |
| Resistance Level | $71.06 | $20.09 |
| Average True Range (ATR) | 3.54 | 0.94 |
| MACD | 0.21 | 0.10 |
| Stochastic Oscillator | 75.98 | 55.49 |
Price Performance
Historical ComparisonAbout AMBA Ambarella Inc.
Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.